Vectura Group PLC (LON:VEC) insider Trevor Phillips sold 240,841 shares of the stock in a transaction on Tuesday, September 27th. The stock was sold at an average price of GBX 139 ($1.81), for a total value of £334,768.99 ($436,978.19).
Vectura Group PLC (LON:VEC) opened at 140.70 on Wednesday. The stock’s 50 day moving average price is GBX 139.40 and its 200-day moving average price is GBX 155.77. The company’s market capitalization is GBX 577.74 million. Vectura Group PLC has a 52 week low of GBX 122.90 and a 52 week high of GBX 200.10.
VEC has been the topic of several research analyst reports. Numis Securities Ltd upped their price target on shares of Vectura Group PLC from GBX 246 ($3.21) to GBX 252 ($3.29) and gave the stock a “buy” rating in a report on Monday, September 19th. Peel Hunt reaffirmed a “buy” rating and issued a GBX 200 ($2.61) price target on shares of Vectura Group PLC in a report on Tuesday, July 19th. Citigroup Inc. reaffirmed a “buy” rating and issued a GBX 215 ($2.81) price target on shares of Vectura Group PLC in a report on Thursday, July 28th. JPMorgan Chase & Co. reaffirmed an “overweight” rating and issued a GBX 230 ($3.00) price target on shares of Vectura Group PLC in a report on Wednesday, July 6th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a GBX 242 ($3.16) price target on shares of Vectura Group PLC in a report on Tuesday, August 30th. Eight research analysts have rated the stock with a buy rating, The company has a consensus rating of “Buy” and an average target price of GBX 222.25 ($2.90).
Vectura Group PLC Company Profile
Vectura Group plc is a product development company. The Company focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases (airways diseases). The Company has eight products marketed by its partners and a portfolio of drugs in clinical development, a number of which have been licensed to pharmaceutical companies.
Receive News & Ratings for Vectura Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.